JCVI recommends switching to 1 dose of HPV vaccine for adolescents

Following a review of the latest evidence, the Joint Vaccination and Immunization Committee (JCVI) released a statement today advising a move from 2 doses to 1 for the routine adolescent HPV vaccination program.

The JCVI regularly reviews all vaccination programs and considers new evidence as it emerges. The Committee has been considering the possible decision for several years and is now of the opinion that there is strong evidence to switch to 1 dose. This view is in line with recent advice from the World Health Organization’s SAGE Committee.

The JCVI held discussions on the proposed changes earlier this year to ensure no evidence was missed and stakeholders’ views were taken into account. The State Secretary for Health will consider the advice and ultimately decide whether the vaccination program needs to be adjusted in the long term.

The HPV program in the UK is aimed at girls and boys aged 12 to 13 and is currently taught as a 2 dose course. According to the new advice, all young people are eligible for 1 dose as part of the routine adolescent program.

The goal of the program is to protect against cancers caused by HPV, including cervical cancer, cancer of the head and neck, and cancers of the anus and genital areas. In England, recently published evidence has shown that the HPV vaccine program has reduced the incidence of cervical cancer in young women who received the vaccine between the ages of 12 and 13 by 87% – ultimately saving thousands of lives.

Dr Vanessa Saliba, Consultant Epidemiologist at UKHSA said:

We know that the HPV vaccine offers excellent protection against cervical cancer and should also prevent a range of other cancers in women and men. The JCVI’s advice is based on compelling evidence that 1 dose of HPV vaccine is as effective as 2 doses, and is in line with recent advice from the World Health Organization.

The advice has now been published and we will ensure we work with the NHS and health partners to support the rollout of any changes to the programme.

We urge everyone who is eligible to use this potentially life-saving vaccine when it is offered. If you missed it, you can catch up until the age of 25.

In addition to the routine adolescent program, there is also a separate HPV vaccination program for gay, bisexual and other men who have sex with men (GBMSM) up to age 45, which is delivered through sexual health clinics. JCVI’s advice about the switch to 1 dose applies to everyone under the age of 25, including GBMSM. Any GBMSM 25 years of age or older will still be offered 2 doses. People with HIV are offered 3 doses, regardless of their age.

/public release. This material from the original organisation/author(s) may be of a point in time, edited for clarity, style and length. The views and opinions are those of the author(s). View the full version here.

Leave a Comment